Biochemistry
-
Synthetic antibodies neutralize SARS-CoV-2 infection of mammalian cells
This article has 17 authors:Reviewed by ScreenIT
-
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
This article has 36 authors:Reviewed by ScreenIT
-
Closing coronavirus spike glycoproteins by structure-guided design
This article has 4 authors:Reviewed by ScreenIT
-
Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays
This article has 13 authors:Reviewed by ScreenIT
-
SARS-CoV-2 envelope protein topology in eukaryotic membranes
This article has 6 authors:Reviewed by ScreenIT
-
Enantiomers of Chloroquine and Hydroxychloroquine Exhibit Different Activities Against SARS-CoV-2 in vitro , Evidencing S -Hydroxychloroquine as a Potentially Superior Drug for COVID-19
This article has 12 authors:Reviewed by ScreenIT
-
Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity
This article has 21 authors:Reviewed by ScreenIT
-
Discovery of potent inhibitors of PL pro CoV2 by screening a library of selenium-containing compounds
This article has 5 authors:Reviewed by ScreenIT
-
Multi-Antigenic Virus-like Particle of SARS CoV-2 produced in Saccharomyces cerevisiae as a vaccine candidate
This article has 18 authors:Reviewed by ScreenIT
-
Binding of the SARS-CoV-2 spike protein to glycans
This article has 10 authors:Reviewed by ScreenIT